Lipella Pharmaceuticals gets ODD for LP-310 to treat GvHD

ODD status is given to drugs meant for the treatment, prevention or diagnosis of a rare disease or condition that impacts lesser than 200,000 people in the US. Credit: Stefan Schweihofer from Pixabay.